Skip to main content
C

Celestra Inc. — Investor Relations & Filings

Ticker · 352770 ISIN · KR7352770002 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 378 across all filing types
Latest filing 2025-04-01 Major Shareholding Noti…
Country KR South Korea
Listing KO 352770

About Celestra Inc.

https://celestrahealth.com/

Celestra Inc. develops and commercializes digital biomarkers for monitoring neurological conditions. The company's core product is the Celestra Health platform, an FDA-designated Class II medical device that provides quantitative gait analysis for patients in their natural environment. The platform utilizes wearable smart insoles equipped with gyroscopes, accelerometers, and pressure sensors to collect movement data. This data is processed by a cloud-based system using advanced machine learning algorithms to measure over 200 aspects of a patient's gait. The system is designed to detect subtle changes in disease progression for conditions such as Multiple Sclerosis and Parkinson’s Disease earlier than traditional clinical assessments. It offers laboratory-grade accuracy, providing clinicians with actionable insights through a proprietary composite index and enabling pharmaceutical firms to assess drug therapy effectiveness more efficiently.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically convertible bonds) by Baro Savings Bank and its special related party in Clinomics. This type of filing is used to notify the market and regulators of significant changes in shareholding positions, which falls under the 'Major Shareholding Notification' category.
2025-04-01 Korean
주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)
Delisting Announcement Classification · 1% confidence The document is a short regulatory notice regarding the suspension of stock trading for Clinomics due to a capital reduction and stock split/consolidation. This is a specific regulatory announcement regarding market operations and does not fit into the other categories like financial reports or director dealings. As it is a formal regulatory notice regarding trading status, it falls under the RNS category.
2025-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official report of the results of a General Meeting of Shareholders (AGM) for the company Clinomics, dated 2025-03-31. It details the outcomes of various agenda items, including the election of directors/auditors and the status of financial statement approvals. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-03-31 Korean
조회공시요구(현저한시황변동)에대한답변(미확정)
Regulatory Filings Classification · 1% confidence The document is a formal response to a regulatory inquiry from the Korea Exchange regarding significant market fluctuations (unusual stock price movement). It provides updates on corporate activities, including capital changes and management decisions, and explains the status of pending items like the audit report submission. As this is a regulatory disclosure required by the exchange and does not fit into specific categories like M&A or dividend announcements, it is classified as a general regulatory filing.
2025-03-21 Korean
기타경영사항(자율공시) (감사보고서 제출 지연)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korean Exchange (KRX) regarding a delay in the submission of an audit report. It is a short, formal announcement explaining that the company has not yet received the audit report from its external auditor due to ongoing data submission processes. Since it is a regulatory announcement regarding a specific corporate event (audit delay) and does not contain the audit report itself, it falls under the 'Regulatory Filings' category.
2025-03-20 Korean
사업보고서제출기한연장신고서 (2024.12)
Report Publication Announcement Classification · 1% confidence The document is a 'Report of Extension of Filing Deadline for Annual Report' (사업보고서제출기한연장신고서) filed by Clinomics. It explicitly states that the company is unable to meet the statutory deadline for submitting its annual report due to delays in the audit process, as confirmed by the external auditor's statement. Since this is a regulatory notification regarding the timing and status of a filing rather than the annual report itself, it falls under the category of a regulatory filing or announcement regarding report publication/status.
2025-03-20 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.